# A Multicentre Phase I-II Study to Investigate the Combination of Bendamustine With Weekly Paclitaxel as First or Second Line Therapy in Patients With Metastatic Breast Cancer

> **NCT00661739** · PHASE1 · COMPLETED · sponsor: **GBG Forschungs GmbH** · enrollment: 38 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Bendamustine

## Key facts

- **NCT ID:** NCT00661739
- **Lead sponsor:** GBG Forschungs GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2010-09
- **Final completion:** 2011-05
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2011-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00661739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00661739, "A Multicentre Phase I-II Study to Investigate the Combination of Bendamustine With Weekly Paclitaxel as First or Second Line Therapy in Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00661739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*